Evercore initiated coverage on the biotech sector and named its seven favorite stocks it calls “The Magnificent Seven.”
Evercore ISI says three years of biotech underperformance may be ending. Gives its 5 favorite stocks
Share This Story, Choose Your Platform!
About the Author: David Hilbern
